Platelet-rich plasma therapy in primary osteoarthritis knee: A prospective observational study
Orthopaedic Journal of Madhya Pradesh Chapter · 2026-01 · 32 (1) · 40-47
DOI: 10.4103/ojmpc.ojmpc_20_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orthopaedic Journal of Madhya Pradesh Chapter, online erschienen am 25.05.2026. Verfasst von Manish Singh Rajpoot und 4 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aim and Objective: To assess the effectiveness of platelet-rich plasma (PRP) in reducing pain and improving function in patients with osteoarthritis (OA) knee.
Introduction
Knee OA is a common degenerative condition causing progressive cartilage loss, pain, and functional limitation. Conventional treatments often offer short-term relief, prompting interest in biological therapies. PRP, containing concentrated platelets and growth factors, has shown potential in promoting tissue healing. This study evaluates the effectiveness of PRP in reducing pain and improving function in primary knee OA. Materials and Methods: This prospective observational study was conducted from March 2022 to December 2023. Fifty patients above 35 years with Kellgren–Lawrence Grades 2–4 primary knee OA were included. PRP was prepared using a double-spin technique from 50 mL of autologous blood, yielding 8 mL of high-quality PRP. A single intra-articular injection was administered under aseptic precautions. Pain and function were assessed using the Visual Analog Scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at baseline, 1 month, 3 months, and 6 months. Statistical comparisons were made using repeated-measures ANOVA and Bonferroni post hoc testing ( P < 0.05).
Results
The mean age of participants was 55.82 ± 10.31 years (24 males, 26 females). Significant improvements were observed in Grades 2 and 3. In Grade 2, WOMAC scores decreased from 71.80 to 33.30 and VAS from 7.5 to 2.5 at 6 months. Grade 3 patients showed similar reductions (WOMAC 73.78–34.52; VAS 7.8–2.8). All improvements in these groups were statistically significant ( P < 0.001). Grade 4 patients ( n = 3) demonstrated no significant changes at any interval. No adverse effects were reported.
Discussion
PRP therapy was highly effective in early and moderate OA, producing consistent improvements in pain and function. Limited response in Grade 4 suggests decreased regenerative capacity in advanced disease.
Conclusion
A single PRP injection is a safe and effective nonsurgical option for mild-to-moderate knee OA. Its benefits are minimal in advanced OA, highlighting the importance of early intervention. Further randomized studies with larger sample sizes are recommended.
Zitieren
APA
Rajpoot, M. S., Vishwakarma, V. K., Khan, R., Panthi, D. K., & Gohiya, A. (2026). Platelet-rich plasma therapy in primary osteoarthritis knee: A prospective observational study. Orthopaedic Journal of Madhya Pradesh Chapter, 32(1), 40-47. https://doi.org/10.4103/ojmpc.ojmpc_20_25
Vancouver
Rajpoot MS, Vishwakarma VK, Khan R, Panthi DK, Gohiya A. Platelet-rich plasma therapy in primary osteoarthritis knee: A prospective observational study. Orthopaedic Journal of Madhya Pradesh Chapter. 2026;32(1):40-47. doi:10.4103/ojmpc.ojmpc_20_25
BibTeX
@article{Rajpoot2026,
author = {Rajpoot, Manish Singh and Vishwakarma, Vaibhav K. and Khan, Rehan and Panthi, Dharam Kabir and Gohiya, Ashish},
title = {Platelet-rich plasma therapy in primary osteoarthritis knee: A prospective observational study},
journal = {Orthopaedic Journal of Madhya Pradesh Chapter},
year = {2026},
volume = {32},
number = {1},
pages = {40--47},
doi = {10.4103/ojmpc.ojmpc_20_25}
}
EUVIMED